LVIS Corporation has launched NeuroMatch Pro, a next-generation AI-powered platform designed to transform epilepsy and seizure management. Building on the success of NeuroMatch, this new system introduces advanced Seizure Detection and Spike Detection capabilities, enabling real-time identification and improved diagnostic accuracy.
AI-Driven Seizure Detection and Spike Analysis
Traditional EEG systems often require extensive manual review, consuming valuable clinician time and leading to potential diagnostic delays. NeuroMatch Pro addresses this challenge by leveraging deep-learning algorithms to detect seizure activity and spike events with exceptional precision, enhancing clinical workflows and patient outcomes.
- Seizure Detection: NeuroMatch Pro utilizes a deep-learning model trained on thousands of hours of 19-channel EEG data, ensuring high accuracy in identifying seizure events. The platform flags potential seizures within an hour, enabling rapid intervention and treatment planning.
- Spike Detection: By recognizing spikes and sharp wave events—key indicators in epilepsy diagnostics—NeuroMatch Pro provides critical insights for neurologists, facilitating more effective and timely treatment strategies.
- Clinician-Centric AI: While the platform automates key detection tasks, physicians retain full control to review, validate, or refine results in real time. This seamless integration of AI and clinical expertise ensures accuracy while optimizing efficiency.
FDA-Cleared and Expanding Globally
NeuroMatch Pro is FDA-cleared and has already been successfully implemented in over 10 hospitals in South Korea. With its recent expansion into the U.S. market, LVIS Corporation aims to support more healthcare institutions by reducing the manual burden of EEG interpretation and enhancing diagnostic precision.
The platform’s ability to automate labor-intensive processes empowers neurologists and healthcare teams to focus on patient care rather than spending excessive time on EEG data analysis. By accelerating the detection of seizure-related activity, NeuroMatch Pro enhances clinical workflows and improves patient outcomes.
The Future of AI in Neurology
The launch of NeuroMatch Pro represents a significant advancement in AI-driven neurology tools. By integrating automated detection with physician oversight, the platform bridges the gap between technology and clinical decision-making. This AI-powered approach offers a more efficient, scalable, and reliable method for EEG analysis, setting a new standard for epilepsy management.
As AI continues to revolutionize healthcare, NeuroMatch Pro stands out as a pioneering tool in neurological diagnostics, demonstrating how artificial intelligence can augment human expertise and enhance patient care.
For more information, visit LVIS Corporation.
